Effect of ovalbumin aerosol exposure on colonization of the porcine upper airway by Pasteurella multocida and effect of colonization on subsequent immune function.
Seventy-three piglets were weaned at 1 week of age, randomly assigned to 10 groups (A to J), accommodated in stainless steel exposure chambers, and exposed continuously to a controlled environment containing aerosolized ovalbumin. The concentrations of ovalbumin dust were as follows (milligrams per cubic meter): A and F, 16.6; B and G, 8.4; C and H, 4.2; D and I, 2.1; E and J, 0. At weekly intervals, the pigs were bled via venipuncture and anesthetized for nasal lavage and tonsilar biopsies performed for subsequent bacteriologic analysis. At 2 weeks of age, the pigs in groups A to E were challenged with toxigenic Pasteurella multocida (10(8) CFU pig(-1)), and at 6 weeks of age, the pigs were euthanatized. At postmortem, the extent of turbinate atrophy was assessed on the snout sections by using a morphometric index. Exposure to aerial ovalbumin resulted in a dose-dependent increase in serum antiovalbumin immunoglobulin G (IgG; P < 0.001) and serum antiovalbumin IgA (P < 0.001). Exposure also caused a significant increase in the numbers of P. multocida organisms isolated from the upper respiratory tract (P < 0.001) and a corresponding increase in turbinate atrophy, as judged by the morphometric index (P < 0.001). Concurrent challenge with P. multocida and ovalbumin resulted in a significant decrease in both the IgG and IgA responses to ovalbumin (P < 0.001). These results show that ovalbumin exposure increases pig susceptibility to P. multocida colonization and that toxigenic P. multocida modifies the serum IgG and IgA responses to ovalbumin in the pig. Both of these effects may enhance the virulence of this respiratory pathogen and so influence the pathogenesis of atrophic rhinitis in pigs.
Department of Clinical Veterinary Sciences, School of Veterinary Sciences, University of Bristol, Langford, England. Tim.Hamilton@bris.ac.uk
T D
TD
Hamilton
J M
JM
Roe
C M
CM
Hayes
A J
AJ
Webster
D000336:Aerosols; D000818:Animals; D000941:Antigens / Q000008:administration & dosage; D004391:Dust / Q000009:adverse effects; D007070:Immunoglobulin A / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D009296:Nasal Cavity / Q000382:microbiology; D010047:Ovalbumin / Q000008:administration & dosage* / Q000276:immunology / Q000633:toxicity; D014066:Palatine Tonsil / Q000382:microbiology; D010326:Pasteurella Infections / Q000276:immunology / Q000382:microbiology / Q000662:veterinary; D016979:Pasteurella multocida / Q000254:growth & development / Q000276:immunology* / Q000472:pathogenicity; D012222:Rhinitis, Atrophic / Q000276:immunology / Q000382:microbiology / Q000662:veterinary; D013552:Swine / Q000276:immunology* / Q000382:microbiology*; D013553:Swine Diseases / Q000276:immunology / Q000382:microbiology; D014774:Virulence
D000336:Aerosols; D000941:Antigens; D004391:Dust; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D010047:Ovalbumin